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The 20 N-terminal residues of the HA2 subunit of influenza hemagglutinin (HA), known as the fusion peptide, play a crucial role in membrane
fusion. Molecular dynamics simulations with implicit solvation are employed here to study the structure and orientation of the fusion peptide in
membranes. As a monomer the α-helical peptide adopts a shallow, slightly tilted orientation along the lipid tail–head group interface. The average
angle of the peptide with respect to membrane plane is 12.4 °. We find that the kinked structure proposed on the basis of NMR data is not stable in
our model because of the high energy cost related to the membrane insertion of polar groups. Because hemagglutinin-mediated membrane fusion
is promoted by low pH, we examined the effect of protonation of the Glu and Asp residues. The configurations of the protonated peptides were
slightly deeper in the membrane but at similar angles. Finally, because HA is a trimer, we modeled helical fusion peptide trimers. We find that
oligomerization affects the insertion depth of the peptide and its orientation with respect to the membrane: a trimer exhibits equally favorable
configurations in which some or all of the helices in the bundle insert obliquely deep into the membrane.
© 2006 Elsevier B.V. All rights reserved.Keywords: Influenza; Hemagglutinin; Fusion peptide; Membrane configuration; Simulation1. Introduction
Influenza is a virus with a high death toll, causing
considerable suffering and imposing a huge economic cost
every year. It has caused several pandemics in the 20th century
in which millions of people died. Viral infection occurs by
endocytosis of the virus and subsequent fusion of the viral
envelope membrane and the endosomal membrane [1,2]. The
membrane fusion process of influenza is mediated by the
homotrimeric protein hemagglutinin (HA) [3–5]. Each HA
monomer contains two subunits, HA1 and HA2. The 20 N-
terminal residues of HA2 are highly conserved and are referred
to as the fusion peptide. The importance of the fusion peptide
has been demonstrated by site-directed mutagenesis [6–8].
HA-mediated membrane fusion is promoted by acidic pH.
Low pH induces a structural change in HA [9,10], which⁎ Corresponding author. Tel.: +1 212 650 8364; fax: +1 212 650 6107.
E-mail address: tlazaridis@ccny.cuny.edu (T. Lazaridis).
1 Formerly M. Huhtala.
0005-2736/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2006.08.008exposes the fusion peptide and allows it to interact with the
target membrane. pH also affects the interaction of the fusion
peptide with the membrane [11–15]. The wild type hemagglu-
tinin fusion peptide (HAFP) has been reported to cause vesicle
lysis at enhanced rates at low pH [12] and a HAFP analogue
shows pH-dependent capability of vesicle lysis [15]. On the
other hand, the fusion peptide has also been shown to fuse
vesicles at a rate independent of pH [16]. The reason may lie in
differences in the studied peptides or in bilayer curvature. The
fusion peptide has been hypothesized to act by perturbing the
membrane or by promoting negative curvature and tension in
the membrane [17–20]. Oligomerization has been reported to
enhance the membrane fusion ability of the HAFP [21].
Significant effort has been put into determining the
membrane structure of the HAFP. The peptide and its analogues
adopt a mainly α-helical conformation upon binding to
membranes [16,22–33], although β-structure is present as
well in varying proportions depending on the environment or
the exact sequence [22,26,27,29,30,32–36]. Most often the
oligomerization state of the fusion peptides is not addressed.
The fusion peptide has been reported to most likely be a
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influenza virus HAFPs and Glu-rich analogues are reported to
form oligomers [23,28,29,37,38]. High peptide concentration
has been reported to promote self-association and β-structure in
HAFPs with solubilizing hydrophilic extension tails [35].
Electron paramagnetic resonance (EPR) studies have
suggested that the α-helical peptide adopts an angle of
approximately 45° [24] or 25° [25,39] with respect to the
membrane plane, although a parallel-to-membrane orientation
for the helices is reported for a glutamic acid-rich analogue [26].
Significant α-helical content [28,30] and oblique orientation
[32] have been suggested as prerequisites for fusion. Obtaining
a high resolution structure has been complicated because of
the high aggregation propensity of the peptide. Han et al.
managed to solubilize the peptides by attaching a hydrophilic
tail (–GCGKKKK) to the fusion peptide sequence, which
prevents aggregation [40]. Based on measurements of the
extended peptide in micelles, Han et al. deduced the atomic
resolution structure of the HAFP to be an inverted V-like
helix–break–helix configuration, in which both the N- and
the C-termini insert into the membrane [14]. The break
between the two helical regions has been later observed also
by Hsu et al. [41] and reported to be significant in the fusion
ability of the peptide [36,42,43].
Theoretical approaches have also been used to study the
configuration adopted by the HAFP and analogous peptides in a
membrane environment [44–49]. Efremov et al. reported that
the peptide adopts a tilted orientation with respect to the
membrane plane based on Monte Carlo simulations [44]. A
Poisson–Boltzmann approach gave an orientation parallel to the
membrane [45]. Spassov et al. employed a generalized Born
implicit description of the membrane and predicted a shallow
tilted insertion angle [46]. Simulations of HAFP with explicit
description of the solvent and the membrane [47–49] predict
that the V-shaped NMR structure is stable in the membrane, at
least for 5 ns–18 ns.
Both the experimental and theoretical work done on the
membrane conformation and orientation of HAFP show a
variety of results. Thus, the issue is far from settled.
Furthermore, although there is considerable evidence that the
fusion peptide may interact with the membrane in oligomeric
form [23,28,29,37,38], the influence of oligomerization on the
membrane configuration of the HAFP has not been assessed.
Here we conduct a simulation study of monomeric and
oligomeric fusion peptides using an implicit environment
description (IMM1) [50,51] with full atomistic detail in the
fusion peptide. The method provides a way to compare the
effective energy of a large number of structures. We find that
HAFP monomers adopt a slightly tilted orientation along the
lipid head group–tail interface but trimers adopt orientations in
which some or all of the peptides insert their N-termini deep into
the non-polar region and adopt an oblique insertion angle.
2. Computational methods
The simulated peptide is the 20 N-terminal residues of the
hemagglutinin protein of influenza strain X31: GLFGAIAG-FIENGWEGMIDG. Both protonation states of the acidic
residues (underlined) are considered. The mutants ΔG1, G1L,
G1E, G4V, and G4E were studied in addition to the wild type
peptide. The CHARMM 19 force field that treats non-polar
hydrogen atoms implicitly is employed to describe the atomic
interactions in the peptide [52,53]. The environment is
described by EFF1.1 in water and IMM1 in the membrane
[50,51]. In the EFF1.1 and IMM1 models an implicit solvation
energy term is added to the CHARMM force field [50,51]. This
describes the self energy of the molecule in its environment. In
addition, the ionic side chains are neutralized and the dielectric
constant is distance dependent to account for the screening
effects of the surrounding solvent. The membrane environment
is described by a hydrophobic slab centered at the plane z=0 Å.
The thickness T of the slab depends on the type of modeled
lipids and typically ranges between 20 Å and 30 Å. A value of
T=26 Å has been used in this work. The transition between the
water and membrane environments is continuous [50,51]. The
solvation parameters and the extent of dielectric screening vary
between the two environments.
The starting structures for the simulations are either ideal-
helices or the V-shaped structures proposed by Han et al.
(Protein Data Bank structures 1IBN and 1IBO) [14]. The
structures are placed at the orientation reported in Ref. [14].
Furthermore, initial orientations in which the ‘V’ is rotated 45°
on the plane of the ‘V’ around the center of mass of the peptide,
or the plane of the ‘V’ is tilted 30° with respect to the membrane
plane, are sampled. By the plane of the ‘V’ we mean here the
plane defined by the first and second principal axes of rotation
of the V-shaped structure. In addition to the insertion depths
proposed in Ref. [14], the V-shaped initial configurations are set
so that the center of mass initially resides either at z=0.0 Å (at
the center of membrane), z=13.0 Å (at the polar–non-polar-
interface) or z=19.5 Å (in the polar region). Three different
protonation states are tried: Charged N- and C-termini and
acidic residues, uncharged N-terminus and acidic residues but
charged C-terminus, and uncharged N- and C-termini and acidic
residues. A total of 216 simulations were run starting from the
NMR structures. The initially α-helical monomer configura-
tions have initial insertion angles between 0 and 90° with
respect to the membrane plane at 5° intervals. The helices are
inserted into the membrane so that the center of mass resides
either at z=0.0 Å, z=13.0 Å, or z=19.5 Å. A total of 228
simulations were run for the wild type peptide from the
α-helical initial structure taking into account the different
protonation states.
In the initial configuration of the trimer the axes of three
identical parallel α-helices span an equilateral triangle with 9 Å
sides. Both termini and the acidic residues are neutralized and
the helices are rotated around their individual axes such that the
three acidic residues are facing the inner core of the bundle and
are thus less exposed to the hydrophobic membrane region. 4
different axial rotation angle combinations were sampled. In
analogy to the monomer, the bundle of three helices is inserted
into the membrane in angles between 0 and 90° at 15° intervals.
Two insertion depths are tried: center of mass at the membrane
center (z=0.0 Å) and at the interface (z=13.0 Å).
Fig. 1. The initial V-shaped configurations (top: pH 7.4, middle: pH 5.0) and
the configuration typically adopted in the relaxation starting from either of the
V-shaped structures (bottom). This particular configuration is obtained from
the pH 5.0 structure with protonated acidic residues and neutralized termini.
The orange plane shows the level of the hydrophilic–hydrophobic interface
(z=13 Å) and the light gray plane the height at which the phosphate head
groups are estimated to reside (z=16 Å). This figure and Figs. 2 and 4 were
produced with the program VMD [56] after which they were rendered and the
planes added with POV-Ray. (For interpretation of the references to colour in
this figure legend, the reader is referred to the web version of this article.)
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the equilateral triangle formed by the cross section of the bundle
being inserted tip-first into the membrane and the other
corresponding to insertion side-first. A total of 112 simulations
were run for the trimers.
The initial configuration is first relaxed at 300 K. In the case
of the trimer the backbone atoms of one of the helices are fixed
for 500 ps relaxation after which the constraints are released and
the system is let to evolve freely for a relaxation period of
500 ps. This ensures that the trimer is properly relaxed and
potential hydrogen bonds have time to form and relax between
the helices. For the monomer no initial fixing period is
necessary and the system is let to evolve freely for 500 ps for
relaxation. In both cases the system is minimized for 300 steps
by adopted basis Newton–Raphson (ABNR) method [52] after
the relaxation to obtain comparable initial configurations. These
configurations are then simulated for 500 ps by employing the
Nosé–Hoover thermostat with heat bath coupling constant
q=100 [54,55]. The dynamics trajectory of the last 400 ps of
this part of the simulation is used to calculate the average
orientation, membrane insertion depth, and effective energy of
the peptide. The angle with respect to the membrane plane and
insertion depth are averaged over frames obtained every 1 ps.
When examining the energetics of the V-shaped structure in
comparison to the interfacial orientation of the peptide, the V-
shaped structures were first positioned with respect to the
membrane as proposed in Ref. [14] and then minimized for 300
steps. Two different protonation states were examined: the V-
shaped structures either had both termini charged and the acidic
residues deprotonated or the termini neutralized and the acidic
residues protonated. The interfacial orientation of a particular
protonation state was picked randomly from the relaxed sample
of highly similar configurations and then minimized.
The fusion peptide monomer is studied with both protonated
and deprotonated N-terminus and acidic residues. As a trimer the
peptides are examined only with uncharged N- and C-terminus
and acidic residues. The effective energy values presented do not
contain the cost of (de)protonation and omit entropic contribu-
tions to the free energy. Therefore the effective energy values are
comparable only within a given protonation state.
3. Results
3.1. Hemagglutinin fusion peptide monomers: the
micelle-determined V-shaped NMR structures are not stable in
the IMM1 model
The most detailed structural information on the HAFP has
been obtained by NMR in micelles. These structures were then
docked onto bilayers using EPR spin labeling measurements.
We first examined the stability of the proposed structures in our
membrane model. We placed the NMR structures in various
protonation states, orientations and insertion depths into the
membrane and relaxed them with molecular dynamics simula-
tions. We found that the peptides relocate rapidly within ca.
100 ps of the initial 500 ps relaxation period to a slightly tilted
configuration along the lipid tail–head group interface. Theinitial minimized V-shaped configurations and the final
configuration are presented in Fig. 1. As the initially V-shaped
configurations relocate to the interface, the helix straightens and
the configurations show no difference to those obtained starting
from ideal-helices.
To find out the reason for the swift interfacial relocation of
the V-shaped HAFP we performed an energetics comparison
between the two configurations. The results are presented in
Table 1. The V-shaped structure is disfavored in comparison to
the interfacial orientation mainly because of the solvation
energy cost due to embedding the polar residues into the
membrane. The same trends are seen for both examined
protonation states. The deeper membrane insertion of the V-
shaped pH 5-structure shows a larger desolvation cost than the
less deep insertion of the V-shaped pH 7.4 structure. Van der
Waals energy contributions also favor the interfacial orientation,
with the more open pH 7.4 structure now disfavored more.
Electrostatic interactions favor the more bent pH 5.0 structure
while disfavor slightly the pH 7.4 structure in comparison to the
interfacial orientation. The favorable electrostatic contribution
is not sufficient to stabilize the pH 5.0 structure. We point out
that the energy values have not been corrected for the cost of
(de)protonation of the termini and the acidic residues and thus
are not comparable between different protonation states.
3.2. Range of configurations accessible by monomeric fusion
peptides as ideal helices
To determine favorable configurations of the fusion peptide
in an unbiased way, a large number of simulations were
performed starting with an ideal helix at different positions
Table 1














Charged N- and C-terminus and acidic residues
V-shaped structure at
pH 5.0 (1IBN)
−492.6 −123.7 −316.4 −91.4
V-shaped structure
at pH 7.4 (1IBO)
−494.4 −154.1 −297.2 −90.4
Interfacial orientation −555.5 −182.9 −302.9 −105.4
Uncharged N- and C-terminus and acidic residues
V-shaped structure at
pH 5.0 (1IBN)
−465.9 −103.1 −315.0 −86.5
V-shaped structure at
pH 7.4 (1IBO)
−459.8 −111.8 −306.4 −83.2
Interfacial orientation −513.6 −143.9 −311.8 −92.1
The abbreviations IBN1 and IBO1 refer to the Protein Data Bank names for the
structures proposed in Ref. [14]. The energy values have not been corrected for
the cost of (de)protonation of the termini and the acidic residues and thus are not
comparable between different protonation states.
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α-helical peptides adopt the same configuration as the initially
V-shaped peptides, see Fig. 2. In addition to the interfacial
orientation we also observe a transmembrane configuration
when the peptide has a charged N-terminus but uncharged
acidic residues, but this orientation has significantly higher
energy. Fig. 3 plots the average effective energy and the average
or smallest distance of the N-terminus from the membrane
center against the average angle of the first 11 residues. The
average angle the monomer makes with respect to the
membrane is 12.4±4.2 Å where the fluctuation in the angle is
estimated by the standard deviation of the averages of
individual runs, see Fig. 3. The individual averages of all four
protonation states fall well within the standard deviation from
one another. Therefore the reported average angle is calculated
over all the protonation states presented in Fig. 3 but
disregarding the transmembrane configurations. In the final
interfacial configurations the α-helical structure is well
preserved at the N-terminal part of the peptide while some
unfolding and occasionally local changes to α-helicity are
observed at the C-terminal region.Fig. 2. Interfacial orientation adopted by the hemagglutinin fusion peptide as an
initially ideal α-helix monomer. The average angle with respect to the membrane
plane is 12.4° and in this particular frame 8.6°. The acidic residues, here
uncharged, are presented as stick-models. The orange plane shows the level of
the hydrophilic–hydrophobic interface (z=13 Å) and the light gray plane the
height at which the phosphate head groups are estimated to reside (z=16 Å).
(For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)On the average, the fusion peptide remains at the membrane
interface as is visible in Fig. 3. Regardless of the charge states of
the termini and the acidic residues, the distance to the membrane
center from the helix corresponds to the interface, ≈14 Å.
Neutralizing the acidic residues moves the peptide a little deeper
into the membrane, but no major difference is observed in the
average insertion. However, neutralizing the N-terminus and the
acidic residues, has an effect on the fluctuations of the peptide.
If the peptide has a neutral N-terminus, the dots corresponding
to the maximum insertion are relocated closer to the membrane
center in Fig. 3. The same can be observed if also the acidic
residues are neutralized but the major contribution appears to be
due to the charge state of the N-terminus, not the acidic residues.
The dynamics trajectories show that the peptide becomes more
mobile when the terminus is uncharged: the amino terminus
takes frequent shallow dips into the membrane but does not
stabilize into the center region. We also studied the effect of
protonation states of the C-terminus (data not shown). Similar
charge-state-related depth fluctuations are observed for theFig. 3. Effective energy and N-terminal insertion depth as a function of
orientation with respect to the membrane plane for the hemagglutinin fusion
peptide as a monomer. Four different protonation states are presented. Please
note that the energies of the states do not include the cost of (de)protonation and
therefore are comparable only within the same protonation state. In the figure
legends the GLU and ASP refer to deprotonated glutamic acid and aspartic acid
residues in the peptide while GLH and ASH correspond to the protonated,
uncharged counterparts.
Fig. 4. The lowest energy configurations for the trimer. The figure on the top
shows the lowest energy configuration obtained in the simulations. The middle
one is the second lowest and represents the interfacial configuration
corresponding to a large majority of the low-energy configurations. The third
lowest is an inserted bundle represented on the bottom. All structures are within
3.5 kcal/mol of each other, see Fig. 5. The orange plane shows the level of the
hydrophilic–hydrophobic interface (z=13 Å) and the light gray plane the height
at which the phosphate head groups are estimated to reside (z=16 Å). (For
interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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brane. In addition, the dynamics runs show that the 20 residue
hemagglutinin fusion peptide behaves in a hinge-like fashion;
residues around 12–14 allow the helix to partially break into
two helical regions connected with a stiff hinge. This region
corresponds to the site of the kink in the configuration proposed
in Ref. [14] and to the observations of Ref. [41]. Because of this
bending, only the 11 N-terminal residues are employed in
defining the angle with respect to the membrane.
It has been hyphothesized that fusion impaired HAFP mutants
might adopt a different orientation than the wild type peptide [47].
Therefore simulations of five different mutants,ΔG1, G1E, G1L,
G4E, and G4V, were performed. Of these, ΔG1, G1E, G1L, and
G4V, have been reported to be fusion impaired in experiments
[57] although later G1L has been shown to allow viral replication
to a small degree [8]. G4E is fusion active but to a lower level than
the wild type [11]. With the exception of the G4V mutant all the
mutants adopt the interfacial orientation in the simulations. ΔG1
adopts the same insertion depth as the wild type peptide but the
removal of the N-terminal glycine causes the peptide to fluctuate
much more in its insertion depth and angle. Mutating the N-
terminal glycine to glutamic acid, G1E, causes the peptide to
adopt a slightly less inserted interfacial orientation than the wild
type. This is equally true for the G4E mutant. Replacing the N-
terminal glycine by the more hydrophobic leucine moves the
peptide slightly deeper into the membrane and induces the N-
terminal to take dips into the membrane center. However, the
interfacial orientation is maintained. In contrast to the wild type
peptide and the other four studiedmutants, the G4Vmutant shows
an oblique orientation with respect to the membrane plane to be
equally likely as the interfacial orientation when the N-terminal of
themutant has been deprotonated.Although valine is only slightly
more hydrophobic than leucine in the G1L mutant which did not
insert, the valine-residue adopts a position in the helix in which it
is significantly more exposed to solvent in the interfacial
orientation than the N-terminal leucine in the G1L mutant. This
explains the emergence of the oblique orientation for this
particular mutant.
3.3. Hemagglutinin fusion peptide trimers
Influenza hemagglutinin is a homotrimer. The crystal
structures of hemagglutinin do not include the fusion peptide
sequence but the trimeric stem region is likely to bring the
peptides close to each other, potentially forming fusion peptide
oligomers. Next we study whether oligomerization has an effect
on the membrane configuration of HAFPs. Because the stem-
region of the hemagglutinin protein is a trimer, we set the
peptides also as a trimer. Three α-helical peptides are initially
bundled and inserted into the membrane at various angles and
depths, and simulated for 1.5 ns of which the last 0.5 ns is used
for calculating the results, see Computational methods.
In the simulations the three peptides typically remain in the
trimeric configuration but the bundle shows structural flex-
ibility. Most typically the bundle relocates to an interfacial
orientation, but slower than the monomer. A significant number
of the trimers do, however, adopt configurations in which eitherone or several of the peptides are inserted deep into the
membrane. A set of low energy configurations for the fusion
peptide trimer are presented in Fig. 4. Fig. 5 shows the average
effective energies of the simulation runs, the corresponding tilt
angles of the helices, and the insertion depths. In Fig. 5 the data
points corresponding to trajectories with extremely high
average energy in comparison to the lowest energy trajectory
are omitted to preserve the clarity of the plots.
The configuration that is lowest in energy in our simulations
has one of the peptides inserted and two remaining at the
interface. This configuration is presented on the top of Fig. 4. In
Fig. 5 the data points corresponding to the low-energy
configuration are highlighted in color: in the lowest-energy
configuration the helices at the interface are at a more tilted
orientation than the monomer, averaging ∼30° and ∼40° with
respect to the membrane plane. The inserted helix has a more
oblique, ca. 55° angle to the membrane plane. The other low-
energy configurations include configurations in which all three
peptides adopt the interfacial orientation (Fig. 4, center) or insert
as a bundle (Fig. 4, bottom). In these configurations the helices
are also more tilted than as monomers. The configurations
presented in Fig. 4 do not show threefold symmetry. In the HA
Fig. 5. Effective energy and orientation with respect to membrane for the
hemagglutinin fusion peptide as a trimer. The open circles refer to individual
helices in the trimer whereas the crosses present the average of the three helices.
A dashed line connects the symbols of each trimer bundle. The low-energy
configurations are marked with matching color in both figures. The colors black,
red and blue correspond to trajectories with the final configuration presented in
Fig. 4 from top to bottom. (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article.)
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residues, that do not adopt any ordered structure in the existing
crystal structures of the low-pH HA2 [58,59]. In the pre-fusion
structure the domain adjacent to the fusion peptide adopts a β-
sheet structure [3]. It is likely that the region next to the fusion
peptide provides enough flexibility to allow the configurations
we observe.
The configurations presented in Fig. 4 reside within an
effective energy window of 3.5 kcal/mol. An energy difference
this small can easily be induced by changes in the peptide
environment, such as differences in membrane composition or
interactions with nearby proteins etc. Oligomerization clearly
creates stable, low-energy configurations in which some or all
of the peptides insert their N-terminus into the membrane and
adopt an oblique insertion angle. The wide variety of stable
configurations also indicates that the peptide has a large
configurational variability and the membrane orientations
should be sensitive to environment.4. Discussion
We studied the membrane configuration of monomeric and
trimeric influenza hemagglutinin fusion peptides. As a
monomer the α-helical wild type peptide adopts a slightly
tilted orientation along the lipid tail–head group interface. For
the trimers the inter-helical interactions induce stable config-
urations in which either one or several of the helices insert
much deeper into the membrane and at a steeper angle with
respect to the membrane plane than the monomeric peptides.
The configurational flexibility of the trimeric peptide is high:
a wide variety of stable configurations was observed to be
comparable in energy. Therefore small changes in the environ-
ment may promote one configuration over the others. Because of
the configurational complexity and flexibility of the trimer, we
cannot be certain that we have sampled the global energy
minimum in our simulations of the trimers. We merely report
observations that the peptide exhibits low energy configurations
that differ significantly in orientation from that of the monomeric
peptide.
Experimental studies of the influenza HAFP configuration in
membrane have given a variety of results. Some predict the
peptide to adopt an α-helical form and insert into the membrane
with N-terminus insertion depth close to the lipid phosphate
group [24,25,39], take a parallel-to-membrane orientation [26]
or adopt a V-shaped configuration in which both termini are
inserted into the hydrophobic membrane [14]. The N-terminal
insertion angle with respect to membrane plane has been
reported to be 45° [24], 25 or 28° depending on pH [25,39], and
21 or 37° depending on pH [14]. Furthermore, Refs. [14,25,39]
use a hydrophobic spin label which may bias the results toward
deeper membrane insertion (Sammalkorpi, M. and Lazaridis T.,
unpublished data). Our results for the monomers clearly favor
the lower values and shallow insertion.
The energetics comparison of the NMR-based high-resolu-
tion structure of the hemagglutinin fusion peptide [14] and the
slightly tilted, essentially straight and less inserted orientation
obtained as the monomer equilibrium configuration in this work
does not support the V-shaped structures of Ref. [14]. The main
reason is the high cost of desolvating the polar residues when
they are inserted into the hydrophobic membrane. We do
observe the kink reported in Ref. [14] but mainly in the
dynamics of the peptide. It may be that the V-shaped
configuration with both termini inserted into the hydrophobic
core has been brought forth in the experiment of Ref. [14] by the
micelle environment. The EPR results were less clear near the
C-terminus. Alternatively, the discrepancy may be due to
limitations of the simulation method. IMM1 is a highly
simplified model of a lipid bilayer. It assumes a perfectly flat,
non-deformable membrane and neglects the connectivity
between headgroups and acyl chains. In reality, lipid molecules
can adapt somewhat to the presence of the peptide. Therefore,
implicit membrane results should be regarded with caution and
should be corroborated, to the extent possible, with explicit
bilayer simulations and further experimentation.
An important issue to consider in the experimental studies
of HAFP membrane configuration is whether the measured
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that the spin labels in different helices are not likely to be in
tertiary or quaternary contact with each other, which the authors
deduce to indicate monomers. On the other hand, it could also
indicate that the relatively long residue arms of the used
methanethiosulfonate spin label point in opposite directions in
an oligomeric configuration. In Ref. [14] the hydrophilic
extension tail that prevents aggregation most likely also affects
oligomerization. However, the same extended peptide that
includes the hydrophilic extension tail, has been reported to
aggregate in a pH-dependent manner at higher concentrations
[35] which indicates that although the tail introduces additional
local charge, some attraction between the peptides remains. The
aggregation was reported to promote β-structure but a
significant content of α-helices were present in the self-
associated samples [35]. The peptide to lipid concentrations
were still much lower than what would be expected as the local
fusion peptide-to-lipid ratio in influenza hemagglutinin
mediated membrane fusion, in which most likely several HA
trimers are required to act in a cooperative way [60,61]. There
is, however, evidence that the fusion peptide forms oligomers
[23,28,29,37,38] and oligomerization of the peptide has also
been reported to promote fusion [21]. The orientations we
obtain for the trimeric peptide agree with the results of Refs.
[14,24,25,39]. The configurational variation observed in the
simulations of the trimer can also explain in part the variation in
observed insertion depths and angles: Refs. [24,39] report the
N-terminal to be at the level of the lipid phosphate group while
Ref. [14] presents N-terminal insertion deep to the hydrophobic
core of the membrane. Similarly, reported angles range between
25 and 45° [14,24,25]. An oligomerization-dependent config-
urational change in the membrane is in line with the pH
dependence reports of HA fusion activity, since at low pH the
acidic residues are more protonated, which acts to stabilize the
inter-helical interactions. At neutral pH the charges at the acidic
residues repel each other and this is likely to prevent the
formation of a helix bundle. A trimeric assembly has been
proposed earlier in Ref. [28] and the orientations of the acidic
residues observed in our simulations are in line with the
proposal of Ref. [28], although we observe flexibility in the
interhelix binding. The high configurational variety observed in
our simulations may play a role in the bilayer destabilization
induced by the HAFP.
The existing theoretical studies treat the HAFP as a monomer
and several reports of oblique insertion exist [44,46–49],
although parallel-to-membrane orientation has been proposed
as well [45]. The slightly tilted interfacial orientation reported in
this work as the monomer structure is in agreement with the
existing studies of HAFP monomers: Efremov et al. reported
based on Monte Carlo simulations in an implicit membrane
model that the functional HAFP analogs and mutants inserted
into the membrane at an angle between 10.3 ° and 18.0 ° to a
depth of approximately 1.4 Å below the membrane surface
(measured from the center of mass of the helix and counting in
the head group region) [44]. Spassov et al. used a generalized
Born solvent model and predicted that the peptide is at interface
at an angle of 20–25° but only if the N-terminal helixunwrapped for 3–4 residues—for an intact helix the orientation
was practically parallel-to-membrane [46].
Regarding simulations in explicit environment, with the
short simulation times there is always the question whether the
system has reached equilibrium, especially for Refs. [47,49] in
which the V-shaped structures of Ref. [14] were used as initial
configurations. Refs. [47,48] predict a backbone insertion depth
only slightly below the phosphate groups, in Ref. [48] minimum
reported side chain distance being approximately 5 Å from the
bilayer center. This is only modestly deeper insertion than the
one we obtain. In Ref. [49] the insertion depth for residue 12 is
reported in line with Ref. [14] but the angle between the helical
segments appears to be larger than in Ref. [14]. In our
simulations the use of IMM1 environment description speeds
the equilibration of the system in comparison to the explicit
environment description: By replacing the lipid and water
molecules by a static implicit environment description diffusion
processes toward equilibrium become orders of magnitude
faster. Thus, it is more certain that the configurations reported in
this work correspond to thermodynamic equilibrium.
It is worth noting that the data presented here cannot be used
to draw any conclusion on the pH dependence of membrane
binding of the fusion peptide. As noted in Computational
methods, energy values of peptides with different protonation
states cannot be compared. It also is not meaningful to compare
the energies of the two NMR structures at the same protonation
state, which, in any case, are highly unstable in our model. The
proper methodology to determine pH dependent membrane
binding free energy is described in a recent publication from our
group [62].
We conclude that peptide–peptide interactions may play a
significant role in the membrane insertion of the influenza
hemagglutinin fusion peptide. This may be related to the
observation that oligomerization enhances fusion activity [21].
Therefore, influenza infection may be prevented, or hindered,
by methods that aim at destabilizing the trimerization.
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